CALIDI BIOTHERAPEUTICS, INC.
Last · NYSE$0.874-0.026 (-2.89%)close · yahoo · 15h ago
Market cap$3.21M3.7M sh
P/E · TTM-0.0fwd -1.0 · eps -35.42 · loss
Beta1.33vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.82$27.20
Volume52.9Ksession
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-27
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.3 years
- Accumulated Deficit High — Accumulated deficit / equity 3768%
Press & signals
- GlobeNewswire
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency
- GlobeNewswire
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
- GlobeNewswire
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags